Literature DB >> 21337816

Etiology of community-acquired pneumonia in hospitalized patients in northern Israel.

Fahmi Shibli1, Bibiana Chazan, Orna Nitzan, Edit Flatau, Hana Edelstein, Orna Blondheim, Raul Raz, Raul Colodner.   

Abstract

BACKGROUND: Community-acquired pneumonia is a common infection and is associated with high rates of morbidity and mortality. Most patients with CAP are treated empirically.
OBJECTIVES: To identify common pathogens causing CAP in hospitalized patients in northern Israel and to evaluate the correlation between etiology and disease severity.
METHODS: We conducted a prospective study of patients with CAP hospitalized at HaEmek Medical Center, Afula. We collected demographic, clinical and laboratory data (blood and sputum cultures, serology, pneumococcal urinary antigen test, and respiratory multiplex-polymerase chain reaction from nasopharyngeal swab). Radiologic evaluation was performed.
RESULTS: A total of 126 patients and 24 controls were enrolled. At least one pathogen was identified in 84 cases (66.7%), more than one in 43 patients (34.1%), and no pathogens in 42 (33.3%). Typical bacteria were found in 23 (18.3%), atypical bacteria in 66 (52.4%), and viruses in 42 (33.3%). The number (%) of patients with pathogens isolated was: Chlamydophila pneumoniae 26 (20.6%), Streptococcus pneumoniae 23 (18.3%), Mycoplasma pneumoniae 23 (18.3%), influenza virus A-B 20 (15.9%), Coxiella burnetti 8 (6.3%), and parainfluenza and adenovirus 13 (10.3%) each. A correlation was found only between a high PORT score on admission and S. pneumoniae, although atypical pathogens did not show class predominance.
CONCLUSIONS: S. pneumoniae, M. pneumoniae and C. pneumoniae were the most common pathogens isolated, while co-infection was very frequent. PORT score did not predict any of the pathogens involved. The choice of empiric antimicrobial treatment for CAP should be made according to local epidemiologic data.

Entities:  

Mesh:

Year:  2010        PMID: 21337816

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  19 in total

Review 1.  Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.

Authors:  Christian Marchello; Ariella Perry Dale; Thuy Nhu Thai; Duk Soo Han; Mark H Ebell
Journal:  Ann Fam Med       Date:  2016-11       Impact factor: 5.166

Review 2.  Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae.

Authors:  Alison Sinclair; Xuanqian Xie; Marty Teltscher; Nandini Dendukuri
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

3.  Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol.

Authors:  Gabriela Abelenda-Alonso; Alexander Rombauts; Carlota Gudiol; Yolanda Meije; Mercedes Clemente; Lucía Ortega; Carmen Ardanuy; Jordi Niubó; Ariadna Padullés; Sebastian Videla; Cristian Tebe; Jordi Carratalà
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

4.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

5.  Bacterial etiologies of five core syndromes: laboratory-based syndromic surveillance conducted in Guangxi, China.

Authors:  Baiqing Dong; Dabin Liang; Mei Lin; Mingliu Wang; Jun Zeng; Hezhuang Liao; Lingyun Zhou; Jun Huang; Xiaolin Wei; Guanyang Zou; Huaiqi Jing
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

6.  Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia.

Authors:  Wesley H Self; Derek J Williams; Yuwei Zhu; Krow Ampofo; Andrew T Pavia; James D Chappell; Weston C Hymas; Chris Stockmann; Anna M Bramley; Eileen Schneider; Dean Erdman; Lyn Finelli; Seema Jain; Kathryn M Edwards; Carlos G Grijalva
Journal:  J Infect Dis       Date:  2015-07-14       Impact factor: 5.226

Review 7.  Severe community-acquired pneumonia.

Authors:  Wendy I Sligl; Thomas J Marrie
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

8.  Outcome risk factors during respiratory infections in a paediatric ward in Antananarivo, Madagascar 2010-2012.

Authors:  Soatiana Rajatonirina; Norosoa Harline Razanajatovo; Elisoa Hariniana Ratsima; Arnaud Orelle; Rila Ratovoson; Zo Zafitsara Andrianirina; Todisoa Andriatahina; Lovasoa Ramparany; Perlinot Herindrainy; Frédérique Randrianirina; Jean-Michel Heraud; Vincent Richard
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

9.  High seroprevalence of Mycoplasma pneumoniae IgM in acute Q fever by enzyme-linked immunosorbent assay (ELISA).

Authors:  Chung-Hsu Lai; Lin-Li Chang; Jiun-Nong Lin; Wei-Fang Chen; Li-Li Kuo; Hsi-Hsun Lin; Yen-Hsu Chen
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

10.  Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia.

Authors:  Reyaz A Para; Bashir A Fomda; Rafi A Jan; Sonaullah Shah; Parvaiz A Koul
Journal:  Lung India       Date:  2018 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.